share_log

BioAffinity Technologies Receives Additional $7.7M From Exercise Of Warrants

BioAffinity Technologies Receives Additional $7.7M From Exercise Of Warrants

生物亲和技术公司通过行使认股权证获得额外770万美元
Benzinga Real-time News ·  2022/09/28 08:16

$bioAffinity Technologies (BIAF.US)$ today announced the receipt of approximately $7.7 million in additional gross proceeds from the exercise of tradeable and non-tradable warrants issued in the Company's September 6, 2022, public offering of securities.

$bioAffinity Technologies (BIAF.US)$今天宣布从行使可交易和不可交易认股权证中获得约770万美元的额外毛收入,这些认股权证是在公司2022年9月6日公开发售证券时发行的。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发